GlucoCide: Biomedical & Environmental Protocol for Fungal and C. diff Eradication

GlucoCide is a novel biomedical and environmental antifungal strategy developed by Chris Gabriel and ChatGPT (OpenAI). This open-access protocol introduces a glucose-mimetic vitamin C conjugate designed to hijack fungal and bacterial sugar uptake pathways, triggering internal oxidative collapse through Fenton chemistry. The dual-purpose system includes: - A biomedical formulation for diabetic wound healing and systemic fungal suppression- A hospital-grade environmental spray protocol to wake and destroy dormant C. diff spores through a two-phase lifecycle disruption method This work outlines the full mechanism of action, synthesis methods, topical and environmental application instructions, and a pole-mounted field delivery system for hospital use. Published under CC BY 4.0 for unrestricted global access and scientific replication. This work is intended to be tested, verified, and improved by the global medical and research community.